Document Detail

Bleeding of a familial cerebral cavernous malformation after prophylactic anticoagulation therapy. Case report.
MedLine Citation:
PMID:  16859253     Owner:  NLM     Status:  MEDLINE    
The risk of hemorrhage in cavernous malformations (CMs) depends on lesion, host, and environmental factors. Anticoagulation therapy is a well-known risk factor for intracerebral bleeding, but the occurrence of hemorrhages in patients with CMs has not been reported. Low molecular weight heparin therapy is generally considered to be safe, although significant hemorrhagic complications have recently been reported. The authors report a case of intralesional bleeding in a CM after prophylactic anticoagulation therapy was administered in a patient with the familial form of the disease. The leaky endothelial structure of CMs may constitute an unexpected target of the vascular effects of heparin.
Eugenio Pozzati; Mino Zucchelli; Anna Federica Marliani; Luca Albini Riccioli
Related Documents :
11883863 - The finding of a somaticdeletion in ret exon 15 clarified the sporadic nature of amedul...
163713 - Vitiligo and dysgammaglobulinemia. a case report and family study.
20480273 - Bilateral spontaneous concurrent rupture of the patellar tendon in a healthy man: case ...
Publication Detail:
Type:  Case Reports; Journal Article     Date:  2006-07-15
Journal Detail:
Title:  Neurosurgical focus     Volume:  21     ISSN:  1092-0684     ISO Abbreviation:  Neurosurg Focus     Publication Date:  2006  
Date Detail:
Created Date:  2006-07-24     Completed Date:  2006-08-18     Revised Date:  2008-05-06    
Medline Journal Info:
Nlm Unique ID:  100896471     Medline TA:  Neurosurg Focus     Country:  United States    
Other Details:
Languages:  eng     Pagination:  e15     Citation Subset:  IM    
Department of Neurosurgery, Bellaria Hospital, Bologna, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Anticoagulants / adverse effects
Brain Neoplasms / complications*,  diagnosis,  physiopathology
Cerebral Cortex / blood supply,  pathology,  physiopathology
Cerebral Hemorrhage / chemically induced*,  physiopathology
Cerebral Veins / drug effects*,  pathology,  physiopathology
Endothelium, Vascular / drug effects,  physiopathology
Genetic Predisposition to Disease / genetics
Hemangioma, Cavernous, Central Nervous System / complications*,  diagnosis,  physiopathology
Heparin, Low-Molecular-Weight / adverse effects*
Leiomyoma / surgery
Magnetic Resonance Imaging
Microtubule-Associated Proteins / genetics
Mutation / genetics
Postoperative Care
Proto-Oncogene Proteins / genetics
Risk Factors
Thrombosis / drug therapy,  prevention & control
Reg. No./Substance:
0/Anticoagulants; 0/Heparin, Low-Molecular-Weight; 0/KRIT1 protein, human; 0/Microtubule-Associated Proteins; 0/Proto-Oncogene Proteins

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Intraoperative rupture of brainstem cavernous malformation. Case report.
Next Document:  Resection of a left insular cavernoma aided by a simple navigational tool. Technical note.